Novo Nordisk Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

38,67 EUR +0,50 EUR +1,30 %

22:52:13

BMN

38,58 EUR +0,47 EUR +1,23 %

17:50:05

GVIE

Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.171,50 Mrd. EUR

KGV14,11Div. Rendite3,60%

WKNA3EU6F

ISINDK0062498333

SymbolNONOF

Novo Nordisk Aktien News

Sortieren:Datum Meistgelesen

19.05.26MotleyFoolWatch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party

15.05.26MotleyFoolBuy, Sell, or Hold Novo Nordisk at $46?

14.05.26ZacksCan Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly's Growing Pressure?

WerbungNovo Nordisk-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

14.05.26BenzingaHere's How Much $100 Invested In Novo Nordisk 15 Years Ago Would Be Worth Today

13.05.26BenzingaNovo Nordisk Highlights New Wegovy Pill Data

12.05.26BenzingaNovo Nordisk Presents New Wegovy Data Showing Strong Weight Loss, Fat Reduction

12.05.26ZacksHere is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock

09.05.26MotleyFoolIs This News From Novo Nordisk a Warning for Eli Lilly Shareholders?

06.05.26Financial TimesNovo Nordisk gets a second chance at weight-loss supremacy

06.05.26MarketWatchThe Wegovy pill saw the fastest take-up in weight-loss drug history. Novo Nordisk only narrowly lifted guidance.

06.05.26Financial TimesNovo Nordisk says US peptide craze boosting Wegovy weight-loss pill sales

06.05.26RTE.ieNovo Nordisk raises outlook as Q1 profit beats forecast

05.05.26BenzingaHere's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 15 Years

04.05.26ZacksNovo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?

29.04.26ZacksNovo Nordisk (NVO) Dips More Than Broader Market: What You Should Know

27.04.26ZacksNovo Nordisk vs. Pfizer: Which Healthcare Giant Is the Better Bet?

24.04.26BenzingaNovo Nordisk Shares Rise After Positive Oral Semaglutide Trial In Children

23.04.26ZacksNovo Nordisk (NVO) Sees a More Significant Dip Than Broader Market: Some Facts to Know

23.04.26BenzingaNovo Nordisk Eyes Approval For Potential First Oral GLP-1 Diabetes Pill In Young Patients

21.04.26ZacksNovo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

17.04.26ZacksNovo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade

17.04.26BenzingaNovo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake

16.04.26ZacksThe Zacks Analyst Blog Highlights Netflix, PepsiCo, Novo Nordisk, Hawthorn Bancshares and Park Aerospace

15.04.26ZacksTop Research Reports for Netflix, PepsiCo & Novo Nordisk

15.04.26MotleyFoolThe $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust

14.04.26BenzingaMove Over Novo Nordisk - This Small Company Study Flags Edge In Fatty Liver Drug

14.04.26BenzingaNovo Nordisk Expands AI Push With ChatGPT Parent OpenAI

10.04.26ZacksNovo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It

09.04.26BenzingaNovo Nordisk Wins EU Nod To Ease Wegovy Injection Delivery

08.04.26ZacksNovo Nordisk (NVO) Increases Yet Falls Behind Market: What Investors Need to Know

04.04.26MotleyFoolEli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight

02.04.26ZacksNovo Nordisk (NVO) Rises Higher Than Market: Key Facts

31.03.26BenzingaSlash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan

30.03.26ZacksInvestors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know

28.03.26MotleyFoolNovo Nordisk: A Strong Contender in the Pharmaceutical Arena

27.03.26MotleyFoolEli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?

27.03.26BenzingaNovo Nordisk Wins FDA Nod For First-Ever Weekly Basal Insulin

26.03.26BenzingaWhat's Happening With Novo Nordisk Stock Today?

25.03.26ZacksNovo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade

24.03.26MotleyFoolThink Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer

Novo Nordisk News

Novo Nordisk News: auf dieser Seite finden Sie alle Novo Nordisk News und Nachrichten zur Novo Nordisk Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.